Actively Recruiting
Phase 3
Age: 18Years +
All Genders
NCT03925662
Mebendazole as Adjuvant Treatment for Colon Cancer
Led by Sherief Abd-Elsalam · Updated on 2019-04-24
40
Participants Needed
1
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
mebendazole treating colon cancer
CONDITIONS
Official Title
Mebendazole as Adjuvant Treatment for Colon Cancer
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Colorectal cancer stage 4
You will not qualify if you...
- Agranulocytosis
- Pregnancy
- Allergy to mebendazole.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Cairo, Egypt
Actively Recruiting
Loading map...
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here